Aris Persidis, Ph.D.
Ron Alfa, MD, Ph.D.
- Vice President, Discovery and Product
- Recursion Pharmaceuticals
Bobbie Ann Austin, Ph.D.
- Program Officer, Drug Development Partnership Programs, NCATS, Office of the Director
- National Institutes of Health
Paul Bogdan, Ph.D.
- Assistant Professor, Department of Electrical Engineering
- University of Southern California
- Senior Manager Market Access and Value Added Medicines
- Medicines for Europe
Rodolphe Hajj, Ph.D.
- Chief Pharmacology Officer
- PharNext SA
Laura Kleiman, Ph.D.
- Executive Director
- Cures Within Reach for Cancer
Daphna Laifenfeld, Ph.D.
- Senior Director, Personalized and Predictive Medicine
- Teva Pharmaceutical Industries
Kevin Pan, Ph.D.
- Chief Executive Officer
- Asieris Pharmaceuticals
- CCO and VP of R&D Operations
- PharNext SA
Michael Pollastri, Ph.D.
- Associate Professor & Chair
- Northeastern University, College of Science
Liven Lagae, MD, Ph.D.
- Professor, Paediatric Neurology
- Katholieke Universiteit Leuven
- Founder & CEO
- Global Cures
Berish Y. Rubin, Ph.D.
- Professor, Department of Biological Sciences
- Fordham University
Charles Hong, MD, Ph.D., FAHA
- Associate Professor of Cardiovascular Medicine, Pharmacology, and Cell and Developmental Biology, Chair, Accelerating Drug Repurposing Incubator
- Vanderbilt University
Michael Tranfaglia, MD
- Medical Director, Chief Scientific Officer
- FRAXA Research Foundation
Gregory Stewart, Ph.D.
- Chief Scientific Officer
Chad Nivens, Ph.D.
- Director, Translational Science, Innovative Medicines & Early Development Biotech Unit
- AstraZeneca Pharmaceutical LP
Clare Thibodeaux, Ph.D.
- Director of Scientific Affairs
- Cures Within Reach
Scott Weir, Pharm.D., Ph.D.
- Frank B. Tyler Cancer Research Professor in Therapeutic Discovery, Director, Institute for Advancing Medical Innovation, Associate Director – Translational Research
- University of Kansas, University of Kansas Cancer Center
Hermann Mucke, Ph.D.
- H.M. Pharma Consultancy